4 курс / Акушерство и гинекология / Гугушвили_Н_А_Клинико_патогенетическое_обоснование_тактики_ведения
.pdfидр. // Вопросы гинекологии, акушерства и перинатологии 2002; - Т.1.
-С. 47-51.
49.Сичинава Л.Г. Перинатальные гипоксемические поражения ЦНС плода
иноворожденного: автореф. дис. …д-ра мед. наук. – М., 1993.
50.Стрижаков А. Н., Давыдов А.И., Белоцерковцева Л. Д., Игнатко И. В.
Физиология и патология плода. – М.:Медицина, 2004. – 356 с.
51.Стрижаков А. Н., Игнатко И. В, Тимохина Е. В., Белоцерковцева Л. Д.
Синдром задержки роста плода. ГЕОТАР-Медиа, 2013
52.Стрижаков А. Н., Михайленко А. Т., Бунин А. Т., Медведев М. В.
Задержка развития плода. К.: Здоровья, 1988.
53.Стрижаков А. Н., Тимохина Т. Ф., Баев О. Р. Фетоплацентарная недостаточность : патогенез, диагностика, лечение // Вопросы гинекологии, акушерства и перинатологии. 2003 – № 2. – С. 53-63
54.Стрижаков А.Н. и др. Морфофункциональные изменения в плаценте при плацентарной недостаточности различной степени тяжести // Вопр.
гин., акуш. и перинатол. – 2010. – Т. 9, № 2. – С. 5–11.
55.Стрижаков А.Н. Медведев М.В. Новые направления ультразвуковой диагностики в перинатальной медицине. //Акушерство и гинекология,- 1991.- №1.-С75-77.
56.Стрижаков А.Н., Медведев М.В., Агеева М.И. Доплерометрическое и доплерэхокардиографическое изучение характера и этапности нарушения гемодинамики плода при внутриутробной задержке его развития. // Акушерство и гинекология.-1992.-№1.-С.22-27.
57.Стрижаков А.Н., Тимохина Е.В., Тарабрина Т.В.. Клиническое значение инсулиноподобного фактора роста при синдроме задержки развития плода. // Вопросы акушерства, гинекологии и перинотологии. 2009. – том8.– №5
58.Стрижаков А.Н., Тимохина Т.Ф., Баев O.P. Фетоплацентарная
недостаточность: патогенез, диагностика, лечение // Вопросы
151
акушерства, гинекологии и перинатологии. 2003. - Т.2. - №2. - С. 53 -
64..
59.Тарабрина Т.В. Клиническое значение исследования ангиогенных факторов роста в прогнозировании синдрома задержки развития плода:
автореф. Дисс. …канд. мед. наук. М., 2010.
60.Федорова М. В., Калашникова Е. П. Плацента и ее роль при беременности. – М.: Медицина, 1986. – 256 с.
61.Федорова М.В., Новикова С.В., Витушко С.А. Прогнозирование состояния плода и новорожденного при ОПГ-Гестозах. //Вестн. Росс,
ассоц. акуш.-гинек. 1997. - №1. - С.58-62.
62.Чернуха Е.А., Комиссарова JI.M., Абубанирова A.M. и др.
Информативность интранатальной кардиотонографии при родоразрешении женщин с маловесными плодами // Акуш. и гин. 1989. - № 1. - С. 33-37.
63.Шабалов Н.П. Неонатология. В 2-х т.- СПб.: СОТИС, 1999.
64.Ширяева Т., Князев Ю. Гормональные факторы и задержка внутриутробного развития. – Врач. – 1998. – С. 22–24.
65.Юдина Е. В., Гурин Ю. Л., Васильева Е. Ю. и др. Допплерография в акушерстве: Итоги Росийского мульотцентрового исследования //
Пренат. Диагн. 2003. – Т. 2. – № 3 – С. 206–214.
66.Ahmed A., Perkins J. Angiogenesis and intrauterine growth restriction // Baillieres Best Pract Res Clin Obstet Gynaecol. – 2000. – Vol. 14 – P. 981 - 998.
67.Albaiges G., Missfelder-Lobos H., Lees C.., Parra M, Nicolaides K.H. Onestage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation // Obstet Gynecol. – 2000. – Vol. 96 – №4 – P. 559-564.
152
68.Alexander G.R., Himes J.H., Kaufman R.B., Mor J., Kogan M. A United States national reference for fetal growth // Obstet Gynecol. – 1996. – Vol. 87 – №2 – P. 163-168.
69.Alfirevic Z., Neilson J.P. Biophysical profile for fetal assessment in high risk pregnancies // Cochrane Database Syst Rev. – 2000. – Vol. 2.
70.American College of Obstetricians and Gynecologists: Intrauterine growth restriction. Ptactice Bulletin No.22 – 2000.
71.Autiero M., Luttun A., Tjwa M., Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders // J Thromb Haemost. – 2003 – Vol.1 – P. 1356–1370.
72.Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., et al. Role of PlGF in the intraand intermolecular cross talk between the VEGF receptors Flt1 and Flk1 // Nat Med. – 2003 – Vol.9 – P. 936–943.
73.Bailey S.M., Sarmandal P., Grant J.M. A comparison of three methods of assessing inter-observer variation applied to measurement of the symphysis-
fundal height // Br J Obstet Gynaecol. – 1989 – Vol. 96 – №11 – P. 12661271.
74.Baker Méio M.D., Lopes Moreira M.E., Sichieri R., Moura A.S. Reduction of IGF-binding protein-3 as a potential marker of intra-uterine growth restriction. // J Perinat Med. – 2009 – Vol. 37 – № 6 P. 689-693.
75.Balcazar H., Haas J. Classification schemes of small-for-gestational age and type of intrauterine growth retardation and its implications to early neonatal mortality // Early Hum Dev. 1990. – Vol. 24 – №3 – P. 219-230.
76.Barker D.J.P. Fetal programming of coronary heart disease // Trends Endocrinol Metab. – 2002 – Vol. 13 – №9 – P. 364–368.
153
77.Barnea E.R., Feldman D., Kaplan M., Morrish D.W. The dual effect of epidermal growth factor upon human chorionic gonadotropin secretion by the first trimester placenta in vitro // Journal of Clinical Endocrinology and Metabolism 1990. – Vol. 71 – P. 923–928.
78.Baschat A. Fetal responses to placental insufficiency: an update // BJOG – 2004 – Vol. 111 – №10 – P. 1031–1041.
79.Baschat A., Cosmi E., Bilardo C.M., Wolf H., Berg C., Rigano S., Germer U., Moyano D., Turan S., Hartung J., Bhide A., Müller T., Bower S., Nicolaides K.H., Thilaganathan B., Gembruch U., Ferrazzi E., Hecher K., Galan H.L., Harman C.R. Predictors of neonatal outcome in early-onset placental dysfunction. // Obstet Gynecol – 2007. – Vol. 109 – №2 Pt 1 – P. 253–261.
80.Baschat A.A., Gembruch U., Harman C.R. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens // Ultrasound Obstet Gynecol – 2001 – Vol. 18 –№6 – P. 571-577.
81.Basel D, Lederer R, Diamant YZ. Longitudinal ultrasonic biometry of various parameters in fetuses with abnormal growth rate // Acta Obstet Gynecol Scand. – 1987 – Vol. 66 – №2 – P. 143-149.
82.Bastide A., Manning F., Harman C., Lange I., Morrison I. Ultrasound evaluation of amniotic fluid: outcome of pregnancies with severe oligohydramnios // Am J Obstet Gynecol. – 1986 – Vol. 154 – №4 – P. 895900.
83.Battaglia F.C., Lubchenco L.O. A practical classification of newborn infants by weight and gestational age // J Pediatr – 1967. – Vol. 71 – №2 – P. 159163.
84.Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy // Nature Reviews. Drug Discovery – 2009. – Vol. 8 – P. 235– 253.
154
85.Beisher N.A. The Effect of maternal enemia upon the fetus // J Reprod Med.
–1971. – Vol. 6 – P. 262-263.
86.Belizán J.M., Villar J., Nardin J.C., Malamud J., De Vicurna L.S. Diagnosis of intrauterine growth retardation by a simple clinical method: measurement of uterine height // Am J Obstet Gynecol. – 1978 – Vol. 131 – №6 – P. 643646.
87.Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction // The Vermont Oxford Network. Am J Obstet Gynecol – 2000. – Vol. 182 – P. 198–206.
88.Böttcher R.T., Niehrs C. Fibroblast growth factor signaling during early vertebrate development // Endocr. Rev. – 2005. – Vol. 26 – №1 – P. 63–77.
89.Branch D.W., Scott J.R., Kochenour N.K., Hershgold E. Obstetric complications associated with the lupus anticoagulant // N Engl J Med. – 1985. – Vol. 313 – №21 – P. 1322-1326.
90.Bujold E., Morency A.M., Roberge S., Lacasse Y., Forest J.C., Giguère Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis // J Obstet Gynaecol Can. – 2009 – Vol. 31 – №9 – P. 818-826.
91.Bukowski R., Burgett A.D., Gei A., Saade G.R., Hankins G.D. Impairment of fetal growth potential and neonatal encephalopthy // Am J Obstet Gynecol. – 2003. – Vol. 188 – №4 – P. 1011-1015.
92.Bukowski R., Uchida T., Smith G.C., Malone F.D., Ball R.H., Nyberg D.A., Comstock C.H., Hankins G.D., Berkowitz R.L., Gross S.J., Dugoff L., Craigo S.D., Timor I.E., Carr S.R., Wolfe H.M., D'Alton M.E. First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Individualized norms of optimal fetal growth: fetal growth potential // Obstet Gynecol. – 2008 – Vol. 111 – №5 – P. 1065-1076.
155
93.Calvert J.P., Crean E.E., Newcombe R.G., Pearson J.F. Antenatal screening by measurement of symphysis-fundus height // Br Med J (Clin Res Ed). – 1982. – Vol. 285 – №6345 – P. 846-849.
94.Cambell S., Dewhurst C.J. Diagnosis of the small-for-dates fetus by serial ultrasonic cephalometry // Lancet – 1971. – Vol. 2 – P. 1002-1015.
95.Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele // Nature – 1996. – Vol. 380 – №6573 – P. 435–439.
96.Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions // Nat Med. – 2001. – Vol. 7 – №5 – P. 575–583.
97.Carrera JM. Intrauterine growth retardation // VIII World Congress of Gyneclogy and Obstetrics (FIGO), Mexico, October 1976.
98.Cellini C., Xu J., Arriaga A., Buchmiller-Crair T.L. Effect of epidermal growth factor infusion on fetal rabbit intrauterine growth retardation and small intestinal development // Journal of Pediatric Surgery. – 2004. – Vol. 39 – P. 891–897.
99.Chang C.H., Yu C.H., Chang F.M., Ko H.C., Chen H.Y. The assessment of normal fetal liver volume by three-dimensional ultrasound // Ultrasound Med Biol. – 2003. – Vol. 29 – №8 – P. 1123-1129.
100.Chang C.H., Yu C.H., Ko H.C., Chen C.L., Chang F.M. Fetal upper arm volume in predicting intrauterine growth restriction: a three-dimensional ultrasound study // Ultrasound Med Biol. – 2005. – Vol. 31 – №11 – P. 1435-1439.
101.Chang C.H., Yu C.H., Ko H.C., Chen C.L., Chang F.M. The efficacy assessment of thigh volume in predicting intrauterine fetal growth restriction by three-dimensional ultrasound // Ultrasound Med Biol. – 2005. – Vol. 31 –
№7 – P. 883-887.
156
102.Chang T.C., Robson S.C., Boys R.J., Spencer J.A. Prediction of the small for gestational age infant: which ultrasonic measurement is best? // Obstet Gynecol. – 1992. – Vol. 80 – №6 – P. 1030-1038.
103.Chang T.C., Robson S.C., Spencer J.A., Gallivan S. Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight // Obstet Gynecol. – 1993. – Vol. 82 – №2 – P. 230-236.
104.Chervenak F.A., Jeanty P., Hobbins J.C. Current status of fetal age and growth assessment // Clin Obstet Gynaecol. – 1983. – Vol. 10 – №3 – P. 423-444.
105.Clapp J.F. 3rd, McLaughlin M.K., Gellis J., Hemphill C., Catalano P.M. Regional distribution of cerebral blood flow in experimental intrauterine growth retardation // Am J Obstet Gynecol. – 1984. – Vol. 150 – №7 – P. 843-846.
106.Clark S.L. Patterns of intrauterine growth retardation // Clin Obstet Gynecol. – 1992. – Vol. 35 – P. 194-201.
107.Clinical Maternal-Fetal Medicine. Ed. by H.N. Winn and J.C. Hobbins / Parthenon Publishing – 2000. – 976p.
108.Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal // Journal of Biological Chemistry – 1962 – Vol. 237 – P. 1555–1562.
109.Combs C.A., Jaekle R.K., Rosenn B., Pope M., Miodovnik M., Siddiqi T.A. Sonographic estimation of fetal weight based on a model of fetal volume // Obstet Gynecol. – 1993. – Vol. 82 – №3 – P. 365-370.
110.Combs CA, Jaekle RK, Rosenn B, Pope M, Miodovnik M, Siddiqi TA Sonographic estimation of fetal weight based on a model of fetal volume // Obstet Gynecol. – 1993. – Vol. 82 – №3 – P. 365-370.
157
111.Coumoul X., Deng C.X. Roles of FGF receptors in mammalian development and congenital diseases // Birth Defects Res C Embryo Today. – 2003. – Vol. 69 – №4 – P. 286-304.
112.Cunningham F.G., Cox S.M., Harstad T.W., Mason R.A., Pritchard J.A. Chronic renal disease and pregnancy outcome // Am J Obstet Gynecol. – 1990. – Vol. 163 – №2 – P. 453-459.
113.Dackor J., Strunk K.E., Wehmeyer M.M., Threadgill D.W. Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos // Placenta – 2007. – Vol. 28 – P. 1211–1218.
114.Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes // Obstet Gynecol. – 2000.
– Vol. 96 – №3 – P. 321-327.
115.De Onis M., Blossner M., Villar J. Levels and patterns of intrauterine growth retardation in developing countries // Eur J Clin Nutr. – 1998. – Vol. 52 –P. 83-93.
116.Derwig I., Lythgoe D.J., Barker G.J., Poon L., Gowland P., Yeung R., Zelaya F., Nicolaides K. Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome // Placenta. – 2013. – 4004 – №13 – P. 593-596.
117.Deutinger J., Bartil W., Pfersmann C., Neumark J., Bernaschek G., Fetal kidney volume and urine production in cases of fetal growth retardation // J. Perinat. Med. – 1987. – Vol. 15 – P. 307-315.
118.Director General World Health Organization: Bridging the gaps. The World Health Report 1995.
119.Divon MY, Haglund B, Nisell H, Otterblad PO, Westgren M. Fetal and neonatal mortality in the postterm pregnancy: the impact of gestational age
158
and fetal growth restriction // Am J Obstet Gynecol. – 1998. – Vol. 178 –
№4 – P. 726-731.
120.Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis // Am J Pathol. – 1995 – Vol. 146 – №5 – P. 1029-1039.
121.Espinoza J., Kusanovic J.P., Bahado-Singh R., Gervasi M.T., Romero R., Lee W., Vaisbuch E., Mazaki-Tovi S., Mittal P., Gotsch F., Erez O., Gomez R., Yeo L., Hassan S.S. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? // J Ultrasound Med. – 2010. – Vol. 29 – №7 – P. 1103-1115.
122.F. Manning. OBJ Management. – 2000. P. 30-45.
123.Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O’Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene // Nature – 1996. – Vol. 380 – №6573 – P. 439–442.
124.Figueras F., Figueras J., Meler E., Eixarch E., Coll O., Gratacos E., Gardosi J., Carbonell X. Customised birthweight standards accurately predict perinatal morbidity // Arch Dis Child Fetal Neonatal Ed. – 2007. – Vol. 92 –
№4 – P. 277-280.
125.Fondacci C., Alsat E., Gabriel R., Blot P., Nessmann C., Evain-Brion D. Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation // Journal of Clinical Investigation – 1994 – Vol. 93 – P. 1149–1155.
126.Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium // Nature – 1995. – Vol. 376 – №6535 – P. 66–70.
127.Forbes K., Westwood M. Maternal growth factor regulation of human placental development and fetal growth // J Endocrinol. – 2010. – Vol. 207 –
№1 – P. 1-16.
159
128.Froen J.F., Gardosi J.O., Thurmann A. et al. Restricted fetal growth in sadden intrauterine unexplained death // Acta Obstet Gynecol Scand. – 2004. – Vol. 83 – P. 801-807.
129.Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts // Lancet. – 1992. – Vol. 339 – №8788 – P. 283-287.
130.Garite T.J., Clark R., Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates // Am J Obstet Gynecol.
–2004. – Vol. 191 – №2 – P. 481-487.
131.Gascoin G., Flamant C. Long-term outcome in context of intra uterine growth restriction and/or small for gestational age newborns // J Gynecol Obstet Biol Reprod (Paris). – 2013. – Vol. 42 – №8 – P. 911-20.
132.Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, Johnson M. Effect of maternal heart disease on fetal growth // Obstet Gynecol. – 2011. – Vol. 117 – №4 – P. 886-891.
133.Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth // J Clin Endocrinol Metab. – 1995. – Vol. 80 – №5 – P. 1548-1555.
134.Gluckman P.D., Harding J.E. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences // Acta Paediatr Suppl. – 1997 – Vol. 422: – P. 69-72.
135.Godfrey K.M., Barker D.J.P. Fetal nutrition and adult disease // Am J Clin Nutr. – 2000. – Vol. 71 (5 Suppl) – P. 1344-1352.
136.Gonzalez J.M., Stamilio D.M., Ural S., Macones G.A., Odibo A.O. Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction // Am J Obstet Gynecol. – 2007. – Vol. 196
–№5 – P. 48-51.
137.Grissa O., Yessoufou A., Mrisak I., Hichami A., Amoussou-Guenou D.,
160